Spellman David A 4
4 · Akebia Therapeutics, Inc. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
Spellman David A
SVP, CFO and Treasurer
Transactions
- Award
Employee Stock Option (Right to buy)
2020-06-30+280,000→ 280,000 totalExercise: $13.58Exp: 2030-06-30→ Common Stock (280,000 underlying)
Footnotes (1)
- [F1]The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.